OBJECTIVE: We investigated the duration of HIV transmission clusters. DESIGN: Fifty-four individuals newly infected at enrollment in the ALIVE cohort were included, all of whom had sequences at an intake visit (T1) and from a second (T2) and/or a third (T3) follow-up visit, median 2.9 and 5.4 years later, respectively. METHODS: Sequences were generated using the 454 DNA sequencing platform for portions of HIV pol and env (HXB2 positions 2717-3230; 7941-8264). Genetic distances were calculated using tn93 and sequences were clustered over a range of thresholds (1--5%) using HIV-TRACE. Analyses were performed separately for individuals with pol sequences for T1 + T2 (n = 40, 'Set 1') and T1 + T3 (n = 25; 'Set 2'), and env sequences for T1 + T2 (n = 47, 'Set 1'), and T1 + T3 (n = 30; 'Set 2'). RESULTS: For pol, with one exception, a single cluster contained more than 75% of samples at all thresholds, and cluster composition was at least 90% concordant between time points/thresholds. For env, two major clusters (A and B) were observed at T1 and T2/T3, although cluster composition concordance between time points/thresholds was low (<60%) at lower thresholds for both sets 1 and 2. In addition, several individuals were included in clusters at T2/T3, although not at T1. CONCLUSION: Caution should be used in applying a single threshold in population studies where seroconversion dates are unknown. However, the retention of some clusters even after 5 + years is evidence for the robustness of the clustering approach in general.
OBJECTIVE: We investigated the duration of HIV transmission clusters. DESIGN: Fifty-four individuals newly infected at enrollment in the ALIVE cohort were included, all of whom had sequences at an intake visit (T1) and from a second (T2) and/or a third (T3) follow-up visit, median 2.9 and 5.4 years later, respectively. METHODS: Sequences were generated using the 454 DNA sequencing platform for portions of HIV pol and env (HXB2 positions 2717-3230; 7941-8264). Genetic distances were calculated using tn93 and sequences were clustered over a range of thresholds (1--5%) using HIV-TRACE. Analyses were performed separately for individuals with pol sequences for T1 + T2 (n = 40, 'Set 1') and T1 + T3 (n = 25; 'Set 2'), and env sequences for T1 + T2 (n = 47, 'Set 1'), and T1 + T3 (n = 30; 'Set 2'). RESULTS: For pol, with one exception, a single cluster contained more than 75% of samples at all thresholds, and cluster composition was at least 90% concordant between time points/thresholds. For env, two major clusters (A and B) were observed at T1 and T2/T3, although cluster composition concordance between time points/thresholds was low (<60%) at lower thresholds for both sets 1 and 2. In addition, several individuals were included in clusters at T2/T3, although not at T1. CONCLUSION: Caution should be used in applying a single threshold in population studies where seroconversion dates are unknown. However, the retention of some clusters even after 5 + years is evidence for the robustness of the clustering approach in general.
Authors: Stéphane Le Vu; Oliver Ratmann; Valerie Delpech; Alison E Brown; O Noel Gill; Anna Tostevin; Christophe Fraser; Erik M Volz Journal: Epidemics Date: 2017-10-20 Impact factor: 4.396
Authors: Joel O Wertheim; Alexandra M Oster; Angela L Hernandez; Neeraja Saduvala; M Cheryl Bañez Ocfemia; H Irene Hall Journal: AIDS Res Hum Retroviruses Date: 2016-05-19 Impact factor: 2.205
Authors: Jeannette L Aldous; Sergei Kosakovsky Pond; Art Poon; Sonia Jain; Huifang Qin; James S Kahn; Mari Kitahata; Benigno Rodriguez; Ann M Dennis; Stephen L Boswell; Richard Haubrich; Davey M Smith Journal: Clin Infect Dis Date: 2012-07-10 Impact factor: 9.079
Authors: Susan H Eshleman; Sarah E Hudelson; Andrew D Redd; Lei Wang; Rachel Debes; Ying Q Chen; Craig A Martens; Stacy M Ricklefs; Ethan J Selig; Stephen F Porcella; Supriya Munshaw; Stuart C Ray; Estelle Piwowar-Manning; Marybeth McCauley; Mina C Hosseinipour; Johnstone Kumwenda; James G Hakim; Suwat Chariyalertsak; Guy de Bruyn; Beatriz Grinsztejn; Nagalingeswaran Kumarasamy; Joseph Makhema; Kenneth H Mayer; Jose Pilotto; Breno R Santos; Thomas C Quinn; Myron S Cohen; James P Hughes Journal: J Infect Dis Date: 2011-10-11 Impact factor: 5.226
Authors: Joel O Wertheim; Sergei L Kosakovsky Pond; Lisa A Forgione; Sanjay R Mehta; Ben Murrell; Sharmila Shah; Davey M Smith; Konrad Scheffler; Lucia V Torian Journal: PLoS Pathog Date: 2017-01-09 Impact factor: 6.823
Authors: Jayna Raghwani; Andrew D Redd; Andrew F Longosz; Chieh-Hsi Wu; David Serwadda; Craig Martens; Joseph Kagaayi; Nelson Sewankambo; Stephen F Porcella; Mary K Grabowski; Thomas C Quinn; Michael A Eller; Leigh Anne Eller; Fred Wabwire-Mangen; Merlin L Robb; Christophe Fraser; Katrina A Lythgoe Journal: PLoS Pathog Date: 2018-07-27 Impact factor: 6.823
Authors: Keylie M Gibson; Margaret C Steiner; Seble Kassaye; Frank Maldarelli; Zehava Grossman; Marcos Pérez-Losada; Keith A Crandall Journal: Front Microbiol Date: 2019-03-08 Impact factor: 5.640
Authors: George K Hightower; Susanne J May; Josué Pérez-Santiago; Mary E Pacold; Gabriel A Wagner; Susan J Little; Douglas D Richman; Sanjay R Mehta; Davey M Smith; Sergei L Kosakovsky Pond Journal: PLoS One Date: 2013-06-28 Impact factor: 3.240
Authors: Andrew D Redd; Nicole A Doria-Rose; Joshua A Weiner; Martha Nason; Matthew Seivers; Stephen D Schmidt; Oliver Laeyendecker; Craig Martens; Daniel Bruno; Brandon F Keele; Nagarajan Raju; Ivelin S Georgiev; Susanna L Lamers; Jacquie Astemborski; Gregory D Kirk; John R Mascola; Margaret E Ackerman; Shruti H Mehta; Thomas C Quinn Journal: J Infect Dis Date: 2020-02-18 Impact factor: 7.759